Opening the virtual EFF, Daniel de Boer, ProQR Founder and CEO, welcomed all attendees and provided an update on the continued clinical development mission ProQR is striving toward, even in these unprecedented times. Audience members then heard from Aniz Girach, MD, ProQR Chief Medical Officer, who outlined the latest research findings from the ProQR sepofarsen program for LCA10.
Following the presentation, Dr Girach was joined by Dr. Ian M. MacDonald, a leading expert in the inherited retinal diseases (IRD) field. Throughout the IRD Expert Perspective session, webinar participants examined the latest LCA10 findings and what they mean for IRD clinical development and research, as well as the impact on the patient community.